Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets

Drug Development and Industrial Pharmacy

Volumn 34, Issue 2, 2008, Pages 171-180

  Gutiérrez Sánchez, Pablo Emilio ^a   Hernández León, Alejandra ^b   Villafuerte Robles, Leopoldo ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Carbopol 971P NF; Floating tablets; Methocel K4M; Metronidazole; Polymer hydration; Sustained release

Indexed keywords

BICARBONATE; CARBOMER; CARBON DIOXIDE; EXCIPIENT; METHYLCELLULOSE; METRONIDAZOLE; POLYMER;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HYDRATION; IN VITRO STUDY; PHYSICAL CHEMISTRY;

ACRYLATES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; METHYLCELLULOSE; METRONIDAZOLE; SODIUM BICARBONATE; SOLUBILITY; TABLETS;

EID: 39849093430     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701506478     Document Type: Article

References (38)

1. Baveja, S. K., Ranga Rao, K. V., & Padmalatha Devi, K. (1988). Relationship between gum content and half-life of soluble β blockers from hydrophilic matrix tablets. Int. J. Pharm., 47, 133-139.
2. Bettini, R., Castellani, P. L., Santi, P., Massimo, G., Peppas, N. A., & Colombo, P. (2001). Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate. J. Control. Release, 70, 383-391.
3. Brazel, C. S., & Peppas, N. A. (2000). Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm, 49, 47-58.
4. Chikhalikar, K., & Moorkath, S. (2002). Carbopol polymers: A versatile range of polymers for pharmaceutical applications. Retrieved Dec. 17, 2007, from http://www.PHARMABIZ.com.
5. Colombo, P., Conte, U., Gazzaniga, A., Maggi, L., Sangelli, M. S., Peppas, N. A., & LaManna, A. (1990). Drug release modulation by physical restrictions of matrix swelling. Int. J. Pharm., 63, 43-48.
6. Colombo, P., Castellani, P. L., Peppas, N. A., Maggi, L., & Conte, U. (1992). Swelling characteristics of hydrophilic matrices for controlled release: New dimensionless number to describe the swelling and release behavior. Int. J. Pharm., 88, 99-109.
7. Efentakis, M., Vlachou, M., & Choulis N. H. (1997). Effects of excipients on swelling and drug release from compressed matrices. Drug Dev. Ind. Pharm., 23, 107-112.
8. Espinoza, R., & Villafuerte, L. (1999). Influence of admixed lactose on pelanserin hydrochloride release from hydroxypropyl methylcellulose matrix tablets. Pharm. Acta Helv., 74, 65-71.
9. Holgado, M. A., Caraballo, I., Alvarez-Fuentes, J., Fernández- Hervás, M. J., Fernández-Arevalo, M., & Rabasco, A. M. (1995). Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets. Int. J. Pharm., 118, 151-160.
10. Huang, Y., Tsai, Y., Yang, W., Chang, J., Wu, P., & Takayama, K. (2004). Once-daily propanolol extended-release tablet dosage form: Formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm., 58, 607-614.
11. Jamzad, S., Tutunji, L., & Fassihi, R. (2005). Analysis of macromolecular changes and drug release from hydrophilic matrix systems. Int. J. Pharm., 292, 75-85.
12. Katzhendler, I., Hoffman, A., Goldberger, A., & Friedman, M. (1997). Modeling of drug release from erodible tablets. J. Pharm. Sci., 86, 110-115.
13. Kavanagh, N., & Corrigan, O. I. (2004). Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices: Influence of agitation and dissolution medium composition. Int. J. Pharm., 279(1-2), 141-152.
14. Khan, G. M., & Zhu, J. B. (1999). Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: Influence of co-excipients on release rate of the drug. J. Control. Release 57, 197-203
15. Kim, H., & Fassihi, R. (1997). Application of binary polymer system in drug release rate modulation: 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci., 86, 323-328.
16. Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983). Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: Effect of entrapped air. J. Pharm. Sci., 72, 1189-1191.
17. Lapidus, H., & Lordi, N. J. (1968). Drug release from compressed hydrophilic matrices. J. Pharm. Sci., 57, 1292-1301.
18. Li, S., Lin, S., Chien, Y. W., Daggy, B. P., & Mirchandani, H. L. (2001). Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPS PharmSciTech, 2(1), article 1.
19. Li, S., Lin, S., Daggy, B. P., Marchandani, H. L., & Chien, Y. W. (2002). Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm., 28, 783-793.
20. Mandal, T. K. (1995). The influence of binding solvents on drug release from hydroxypropyl methylcellulose tablets. Drug Dev. Ind. Pharm., 21, 1389-1397.
21. Martínez-González, I., & Villafuerte-Robles, L. (2003). Influence of enteric citric acid on the release profile of 4-aminopyridine from HPMC matrix tablets. Int. J. Pharm., 251(1-2), 183-193.
22. Martínez-González, I., & Villafuerte-Robles, L. (2004). Influence of enteric lactose on the release profile of 4-aminopyridine from HPMC matrix tablets. Pharm. Dev. Tech., 9, 145-153.
23. Papadimitriou, E., Buckton, G., & Efentakis, M. (1993). Probing the mechanism of swelling of hydroxypropylmethylcellulose matrices. Int. J. Pharm., 98, 57-62.
24. Ranga Rao, K. V., Padmalatha Devi, K., & Buri P. (1988). Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm., 14(15-17), 2299-2320.
25. Rinaki, E., Valsami, G., & Macheras P. (2003). The power law can describe the "entire" drug release curve from HPMC-based matrix tablets: A hypothesis. Int. J. Pharm., 255, 199-207.
26. Risbud, M. V., Hardikar, A. A., Bhat, S. V., & Bhonde, R. R. (2000). pH-sensitive freeze dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J. Control. Release, 68, 23-30.
27. Schott, H. (1992). Kinetics of swelling of polymers and their gels. J. Pharm. Sci., 81, 467-470.
28. Singh, B. N., & Kim, K. H. (2000). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J. Control. Release, 63, 235-259.
29. Singla, A., Chawla, M., & Singh, A. (2000). Potential applications of carbomer in oral mucoadhesive controlled drug delivery systems: A review. Drug Dev. Ind. Pharm., 26, 913-924.
30. Sheth, P. R., & Tossounian, J. L. (1979). Sustained release formulations. (pp. 1-2). United States patent 4, 140, 755.
31. Tapia-Albarran, M., & Villafuerte-Robles, L. (2004). Assay of amoxicillin sustained release from matrix tablets containing different proportions of Carbopol 971P NF. Int. J. Pharm., 273, 121-127.
32. Troz de Ilarduya, M. C., Martin, C., Goñi, M. M., Martínez-Ohárris, M. C., (1997). Oxazepem dissolution rate from hydroxypropylmethylcellulose matrices. Drug Dev. Ind. Pharm. 23, 393-396.
33. Varma, M., Singla, A. K., & Dhawan, S. (2004). Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol. Drug Dev. Ind. Pharm., 30, 545-553.
34. Vigoreaux, V., & Ghaly, E. S. (1994). Fickian and relaxational contribution quantification of drug release in a swellable hydrophilic polymer matrix. Drug Dev. Ind. Pharm., 20, 2519-2526.
35. Wu, Y., & Fassihi, R. (2005). Stability of metronidazole, tetracycline HCl and famotidine alone and in combination. Int. J. Pharm., 290, 1-13.
36. Xu, G., & Groves, M. J. (2001). Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets. J. Pharm. Pharmacol., 53, 49-55.
37. Xu, X., Sun, M., Zhi, F., & Hu, Y. 2006. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. Int. J. Pharm., 310, 139-145.
38. Yang, L., Eshraghi, J., & Fassihi, R. (1999). A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: In vitro evaluation. J. Control. Release 57, 215-222.